Carsten Linnemann

Carsten Linnemann is the founder of Neogene Therapeutics. Neogene Therapeutics has raised $110M in total funding. Latest round: Series A.

About Carsten Linnemann

Carsten Linnemann is the founder, President, Chief Executive Officer, and Director of Neogene Therapeutics. He founded the company in 2018 to develop next-generation T-cell receptor (TCR-T) therapies for solid tumors. Neogene Therapeutics was acquired by AstraZeneca in 2023.

Carsten Linnemann at a glance

More founders in Cambridge, Massachusetts (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library